Tilray - TLRY Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TLRY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View TLRY analyst ratings or view top-rated stocks.

12 brokers have issued twelve-month price objectives for Tilray's shares. Their TLRY share price forecasts range from $3.00 to $12.00. On average, they predict the company's stock price to reach $6.78 in the next twelve months. This suggests a possible upside of 69.5% from the stock's current price.
View analysts price targets for TLRY or view top-rated stocks among Wall Street analysts.

Tilray's stock was trading at $7.03 at the beginning of 2022. Since then, TLRY shares have decreased by 43.1% and is now trading at $4.00.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 6th 2022.
View our TLRY earnings forecast.

Tilray Inc (NASDAQ:TLRY) announced its quarterly earnings results on Thursday, July, 28th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.27. The business earned $153.30 million during the quarter, compared to the consensus estimate of $151.53 million. Tilray had a negative net margin of 71.52% and a negative trailing twelve-month return on equity of 4.14%. Tilray's quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.11) earnings per share.

32 employees have rated Tilray Chief Executive Officer Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among the company's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Block (SQ).

(TLRY) raised $135 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Tilray's stock is owned by many different institutional and retail investors. Top institutional shareholders include Public Sector Pension Investment Board (0.23%), Mirae Asset Global Investments Co. Ltd. (0.22%), AdvisorShares Investments LLC (0.19%), Simplex Trading LLC (0.00%), TD Asset Management Inc. (0.17%) and California Public Employees Retirement System (0.15%). Insiders that own company stock include Brendan Kennedy, Carl A Merton, Christine StClare, James R Meiers, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends.

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLRY stock can currently be purchased for approximately $4.00.

Tilray (NASDAQ:TLRY) has a market capitalization of $2.15 billion and generates $628.37 million in revenue each year. The company earns $-476,800,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis.

The company employs 2,100 workers across the globe.

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The official website for the company is www.tilray.com. The company can be reached via phone at 206-432-9325.